lobbying_filings_raw: 5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012 | Q3 | 304931 | EMERGENT BIOSOLUTIONS INC. | 181344 | EMERGENT BIOSOLUTIONS INC | 2011 | third_quarter | 2011-10-19T11:09:38.977000-04:00 | 630000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012/", "filing_uuid": "5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2011, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/5d4c8b09-9ea3-4ca3-9d2e-dbc4e9993012/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "630000.00", "expenses_method": "c", "expenses_method_display": "Method C - Reporting amounts under section 162(e) of the Internal Revenue Code", "posted_by_name": "Allen M Shofe, Senior Vice President Corporate Affairs", "dt_posted": "2011-10-19T11:09:38.977000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1455 Pennsylvania Avenue, NW", "registrant_address_2": "SUITE 1225", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20004", "registrant": {"id": 304931, "url": "https://lda.senate.gov/api/v1/registrants/304931/", "house_registrant_id": 38213, "name": "EMERGENT BIOSOLUTIONS INC.", "description": null, "address_1": "1455 Pennsylvania Avenue, NW", "address_2": "SUITE 1225", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "LIZ HANPETER", "contact_telephone": "+1 202-270-7978", "dt_updated": "2026-01-20T20:36:48.745096-05:00"}, "client": {"id": 181344, "url": "https://lda.senate.gov/api/v1/clients/181344/", "client_id": 12, "name": "EMERGENT BIOSOLUTIONS INC", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-07-26"}, "lobbying_activities": [{"general_issue_code": "DIS", "general_issue_code_display": "Disaster Planning/Emergencies", "description": "Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines;\nH.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\nH.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;\nImplementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 30597, "prefix": null, "prefix_display": null, "first_name": "ALLEN", "nickname": null, "middle_name": null, "last_name": "SHOFE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 1102, "prefix": null, "prefix_display": null, "first_name": "ASHLEY", "nickname": null, "middle_name": null, "last_name": "BRATICH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 47773, "prefix": null, "prefix_display": null, "first_name": "CHRIS", "nickname": null, "middle_name": null, "last_name": "FRECH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53714, "prefix": null, "prefix_display": null, "first_name": "JILL", "nickname": null, "middle_name": null, "last_name": "HAMAKER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines;\nH.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\nH.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;\nImplementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 30597, "prefix": null, "prefix_display": null, "first_name": "ALLEN", "nickname": null, "middle_name": null, "last_name": "SHOFE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 1102, "prefix": null, "prefix_display": null, "first_name": "ASHLEY", "nickname": null, "middle_name": null, "last_name": "BRATICH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 47773, "prefix": null, "prefix_display": null, "first_name": "CHRIS", "nickname": null, "middle_name": null, "last_name": "FRECH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53714, "prefix": null, "prefix_display": null, "first_name": "JILL", "nickname": null, "middle_name": null, "last_name": "HAMAKER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HOM", "general_issue_code_display": "Homeland Security", "description": "Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines;\nH.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\nH.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;\nImplementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 30597, "prefix": null, "prefix_display": null, "first_name": "ALLEN", "nickname": null, "middle_name": null, "last_name": "SHOFE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 1102, "prefix": null, "prefix_display": null, "first_name": "ASHLEY", "nickname": null, "middle_name": null, "last_name": "BRATICH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 47773, "prefix": null, "prefix_display": null, "first_name": "CHRIS", "nickname": null, "middle_name": null, "last_name": "FRECH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53714, "prefix": null, "prefix_display": null, "first_name": "JILL", "nickname": null, "middle_name": null, "last_name": "HAMAKER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |